COVID-19 vaccine acceptance among pregnant, breastfeeding, and nonpregnant reproductive-aged women. 2021

Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
From the Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY.

Although mass vaccination against COVID-19 may prove to be the most efficacious end to this deadly pandemic, there remain concern and indecision among the public toward vaccination. Because pregnant and reproductive-aged women account for a large proportion of the population with particular concerns regarding vaccination against COVID-19, this survey aimed at investigating their current attitudes and beliefs within our own institution. This study aimed to understand vaccine acceptability among pregnant, nonpregnant, and breastfeeding respondents and elucidate factors associated with COVID-19 vaccine acceptance. We administered an anonymous online survey to all women (including patients, providers, and staff) at our institution assessing rates of acceptance of COVID-19 vaccination. Respondents were contacted in 1 of 3 ways: by email, advertisement flyers, and distribution of quick response codes at virtual town halls regarding the COVID-19 vaccine. Based on their responses, respondents were divided into 3 mutually exclusive groups: (1) nonpregnant respondents, (2) pregnant respondents, and (3) breastfeeding respondents. The primary outcome was acceptance of vaccination. Prevalence ratios were calculated to ascertain the independent effects of multiple patient-level factors on vaccine acceptability. The survey was administered from January 7, 2021, to January 29, 2021, with 1012 respondents of whom 466 (46.9%) identified as non-Hispanic White, 108 (10.9%) as non-Hispanic Black, 286 (28.8%) as Hispanic, and 82 (8.2%) as non-Hispanic Asian. The median age was 36 years (interquartile range, 25-47 years). Of all the respondents, 656 respondents (64.8%) were nonpregnant, 216 (21.3%) were pregnant, and 122 (12.1%) were breastfeeding. There was no difference in chronic comorbidities when evaluated as a composite variable (Table 1). A total of 390 respondents (39.2%) reported working in healthcare. Nonpregnant respondents were most likely to accept vaccination (457 respondents, 76.2%; P<.001) with breastfeeding respondents the second most likely (55.2%). Pregnant respondents had the lowest rate of vaccine acceptance (44.3%; P<.001). Prevalence ratios revealed all non-White races except for non-Hispanic Asian respondents, and Spanish-speaking respondents were less likely to accept vaccination (Table 3). Working in healthcare was not found to be associated with vaccine acceptance among our cohort. In this survey study of only women at a single institution, pregnant respondents of non-White or non-Asian races were more likely to decline vaccination than nonpregnant and breastfeeding respondents. Working in healthcare was not associated with vaccine acceptance.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001942 Breast Feeding The nursing of an infant at the breast. Breast Fed,Breastfed,Milk Sharing,Wet Nursing,Breast Feeding, Exclusive,Breastfeeding,Breastfeeding, Exclusive,Exclusive Breast Feeding,Exclusive Breastfeeding,Sharing, Milk
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000086663 COVID-19 Vaccines Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19. 2019 Novel Coronavirus Vaccine,2019 Novel Coronavirus Vaccines,2019-nCoV Vaccine,2019-nCoV Vaccines,COVID 19 Vaccine,COVID-19 Vaccine,COVID-19 Virus Vaccine,COVID-19 Virus Vaccines,COVID19 Vaccine,COVID19 Vaccines,COVID19 Virus Vaccine,COVID19 Virus Vaccines,Coronavirus Disease 2019 Vaccine,Coronavirus Disease 2019 Vaccines,Coronavirus Disease 2019 Virus Vaccine,Coronavirus Disease 2019 Virus Vaccines,Coronavirus Disease-19 Vaccine,Coronavirus Disease-19 Vaccines,SARS Coronavirus 2 Vaccines,SARS-CoV-2 Vaccine,SARS-CoV-2 Vaccines,SARS2 Vaccine,SARS2 Vaccines,2019 nCoV Vaccine,2019 nCoV Vaccines,COVID 19 Vaccines,COVID 19 Virus Vaccine,COVID 19 Virus Vaccines,Coronavirus Disease 19 Vaccine,Coronavirus Disease 19 Vaccines,SARS CoV 2 Vaccine,SARS CoV 2 Vaccines,Vaccine, 2019-nCoV,Vaccine, COVID 19,Vaccine, COVID-19,Vaccine, COVID-19 Virus,Vaccine, COVID19,Vaccine, COVID19 Virus,Vaccine, Coronavirus Disease-19,Vaccine, SARS-CoV-2,Vaccine, SARS2,Vaccines, 2019-nCoV,Vaccines, COVID-19,Vaccines, COVID-19 Virus,Vaccines, COVID19,Vaccines, COVID19 Virus,Vaccines, Coronavirus Disease-19,Vaccines, SARS-CoV-2,Vaccines, SARS2,Virus Vaccine, COVID-19,Virus Vaccine, COVID19,Virus Vaccines, COVID-19,Virus Vaccines, COVID19
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
October 2023, Disaster medicine and public health preparedness,
Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
August 2021, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
December 2021, Journal of public health (Oxford, England),
Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
June 2022, Annals of medicine and surgery (2012),
Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
December 2022, Cureus,
Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
April 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
April 2022, Preventive medicine reports,
Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
January 2024, International journal of women's health,
Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
January 2017, JAMA,
Desmond Sutton, and Mary D'Alton, and Yijia Zhang, and Ka Kahe, and Ana Cepin, and Dena Goffman, and Anna Staniczenko, and Hope Yates, and Anna Burgansky, and Jaclyn Coletta, and Zev Williams, and Cynthia Gyamfi-Bannerman
January 2022, PloS one,
Copied contents to your clipboard!